Simon Buckingham
Direktor/Vorstandsmitglied bei Vaxxilon AG
Aktive Positionen von Simon Buckingham
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Vaxxilon AG
 Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The company is based in Reinach, Switzerland. | Direktor/Vorstandsmitglied | - | - |
| Can Too Foundation | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Simon Buckingham
Ehemalige bekannte Positionen von Simon Buckingham
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SYNTARA LIMITED | Direktor/Vorstandsmitglied | 25.07.2012 | 22.11.2018 |
| Independent Dir/Board Member | 25.07.2012 | 26.03.2015 | |
| ANTERIS TECHNOLOGIES LTD | Direktor/Vorstandsmitglied | 17.02.2017 | 04.10.2018 |
| MELODIOL GLOBAL HEALTH LIMITED | Direktor/Vorstandsmitglied | 24.05.2016 | 05.05.2017 |
| ACTELION | Corporate Officer/Principal | 19.05.2010 | 01.01.2011 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Präsident | - | 01.01.2005 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.01.1997 | 01.01.1997 |
| F. Hoffmann La-Roche (Australia) | Vertrieb & Marketing | 01.01.1995 | 01.01.1995 |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Simon Buckingham
| The University of Sydney | Undergraduate Degree |
| University of Melbourne | Doctorate Degree |
| Australian Graduate School of Management | Undergraduate Degree |
Statistik
International
| Australien | 9 |
| Schweiz | 4 |
| Japan | 2 |
Operativ
| Director/Board Member | 6 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 2 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SYNTARA LIMITED | Health Technology |
| MELODIOL GLOBAL HEALTH LIMITED | Health Technology |
| ANTERIS TECHNOLOGIES LTD | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
| F. Hoffmann La-Roche (Australia) | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
| Actelion Pharmaceuticals Australia Pty Ltd. | |
Vaxxilon AG
Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The company is based in Reinach, Switzerland. | Health Technology |
| Can Too Foundation |
- Börse
- Insiders
- Simon Buckingham
- Erfahrung
